22nd Century Group logo
22nd Century Group XXII

Quarterly report 2026-Q1
added 05-07-2026

report update icon

22nd Century Group Cash Conversion Cycle 2011-2026 | XXII

Annual Cash Conversion Cycle 22nd Century Group

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009
108 19 113 63.7 83.7 40.6 16 18.7 46.4 51.5 59.3 896 1.07 K -179 -329 - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
1.07 K -329 139

Quarterly Cash Conversion Cycle 22nd Century Group

2026-Q1 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- 73 73.2 31.6 - 3.24 -15.8 -0.32 - 284 236 189 - 51.7 44.5 24.5 - 35.1 33.6 39 27 39 44 27.6 10.9 16 17.8 17.9 11.1 19.7 17.8 26.2 14.7 41.8 49.4 20.4 1.12 1.21 1.32 1.39 1.59 45.8 2.03 3.79 - 352 - - - 6 K - - - - - - - 20.4 44.2 -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
6 K -15.8 186

Cash Conversion Cycle of other stocks in the Biotechnology industry

Issuer Cash Conversion Cycle Price % 24h Market Cap Country
FSD Pharma FSD Pharma
HUGE
3.11 K - 5743.5 % $ 69.7 M canadaCanada
Happiness Biotech Group Limited Happiness Biotech Group Limited
HAPP
-3.12 K - 1.35 % $ 17.8 M chinaChina
AgeX Therapeutics AgeX Therapeutics
AGE
186 - -10.17 % $ 12.2 K usaUSA
Coherus BioSciences Coherus BioSciences
CHRS
149 $ 1.73 5.18 % $ 203 M usaUSA
I-Mab I-Mab
IMAB
-1.97 K - - $ 866 M chinaChina
Celldex Therapeutics Celldex Therapeutics
CLDX
-3.74 K $ 31.65 2.59 % $ 2.1 B usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
12.8 - - $ 40.3 B usaUSA
AstraZeneca PLC AstraZeneca PLC
AZN
-58 - - $ 96.9 B britainBritain
CRISPR Therapeutics AG CRISPR Therapeutics AG
CRSP
1.1 K $ 53.52 3.74 % $ 4.81 B schweizSchweiz
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
17 - -1.52 % $ 24.7 M usaUSA
Compugen Ltd. Compugen Ltd.
CGEN
-82.7 $ 2.68 1.13 % $ 250 M israelIsrael
Midatech Pharma plc Midatech Pharma plc
MTP
82.8 - -18.52 % $ 27.3 M britainBritain
Enlivex Therapeutics Ltd. Enlivex Therapeutics Ltd.
ENLV
-981 $ 0.78 14.04 % $ 35.6 M israelIsrael
Esperion Therapeutics Esperion Therapeutics
ESPR
99.7 $ 3.13 0.32 % $ 651 M usaUSA
Eton Pharmaceuticals Eton Pharmaceuticals
ETON
115 $ 31.66 1.18 % $ 852 M usaUSA
Affimed N.V. Affimed N.V.
AFMD
31.4 - -34.95 % $ 21.5 M germanyGermany
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
104 - - - russiaRussia
Celyad Oncology SA Celyad Oncology SA
CYAD
-55.7 K - - $ 12.5 M belgiumBelgium
Berkeley Lights Berkeley Lights
BLI
214 - -7.31 % $ 87 M usaUSA
Generation Bio Co. Generation Bio Co.
GBIO
47.6 - - $ 344 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
-2.15 K - - $ 7.46 M israelIsrael
Grifols, S.A. Grifols, S.A.
GRFS
0.000171 $ 8.08 0.9 % $ 5.49 B spainSpain
Hutchison China MediTech Limited Hutchison China MediTech Limited
HCM
95.8 $ 11.72 -0.26 % $ 10.1 B chinaChina
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
-1.6 K - -4.36 % $ 27 M usaUSA
Heron Therapeutics Heron Therapeutics
HRTX
751 $ 0.9 2.13 % $ 150 M usaUSA
Anika Therapeutics Anika Therapeutics
ANIK
192 $ 14.76 -0.87 % $ 212 M usaUSA
Advaxis Advaxis
ADXS
-82.3 K - -9.65 % $ 45.9 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
-34.3 K - 5.93 % $ 314 M canadaCanada
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
126 - - $ 26.5 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
-1.92 - 1.93 % $ 17.4 M usaUSA